Goldman Sachs’s Accendra Health ACH Stock Holding History

Goldman Sachs’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-45,600	Closed	-$1.71M	–	7131
2016 Q2	$1.71M	Hold	45,600	–	–	﹤0.01%	3755
2016 Q1	$1.84M	Sell	45,600 -192,000	-81%	-$7.15M	﹤0.01%	3559
2015 Q4	$8.55M	Buy	+237,600	New	+$8.6M	﹤0.01%	2371
2015 Q3	–	Sell	-175,000	Closed	-$5.95M	–	7436
2015 Q2	$5.95M	Buy	+175,000	New	+$5.9M	﹤0.01%	2819

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's ACH Position: Q1 2026 in Review

Goldman Sachs increased its Accendra Health (ACH) stake by 41% in Q1 2026, buying an estimated $633K and bringing the position to 941,173 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #4472.

Goldman Sachs first reported a position in ACH in Q2 2013 and has held it in 52 quarters since. The position peaked at $62M in Q4 2021. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

Goldman Sachs held 941,173 shares of Accendra Health worth $2.15M as of Q1 2026.
Goldman Sachs bought 275,048 Accendra Health shares in Q1 2026, an estimated $633K.
Accendra Health made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4472 holding.
Goldman Sachs first reported a position in Accendra Health in Q2 2013 and has held it in 52 quarters since.
Goldman Sachs's Accendra Health position peaked at $62M in Q4 2021.
142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.